Insider screener

Period: 12 months Type of trade: Sold × Plan: Discretionary × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

23,037 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

23,037 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

23,037 decisions over 12 months Remove this filter
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

23,037 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
23,037 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
23,037 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

23,037 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
20 Jan 2026
Mandell Crawley Chief Client Officer
Sold at will 5×
$1.44M 7,860 at 183.45
10.3%
Not planned
20 Jan 2026
Rebecca Taub Director
Sold at will
$1.10M 2,238 at 490.77
0.5%
Not planned
20 Jan 2026
Sold at will
$1.03M 2,700 at 380.60
17.0%
Not planned
20 Jan 2026
Arturo Md Molina Chief Medical Officer
Sold at will
$784.71K 9,514 at 82.48
8.9%
Not planned
20 Jan 2026
Asif Ali Chief Financial Officer
Sold at will
$708.34K 8,588 at 82.48
9.9%
Not planned
20 Jan 2026
Joanne Quan Chief Medical Officer
Sold at will
$623.85K 6,911 at 90.27
37.9%
Not planned
20 Jan 2026
Mark N. Tompkins 10% owner
Sold at will 2×
$620.62K 30,000 at 20.69
1.5%
Not planned
20 Jan 2026
Nicholas Hobbs EVP and COO
Sold at will
$613.58K 3,038 at 201.97
3.3%
Not planned
20 Jan 2026
Roger E. Susi CEO, President, Chairman · indirect
Sold at will 3×
$509.22K 5,000 at 101.84
0.2%
Not planned
20 Jan 2026
Kang Sun Director
Sold at will
$476.27K 43,185 at 11.03
3.0%
Not planned
20 Jan 2026
Sold at will
$458.56K 16,548 at 27.71
0.4%
Not planned
20 Jan 2026
Cyrus Harmon Director
Sold at will
$268.80K 10,000 at 26.88
1.4%
Not planned
20 Jan 2026
los Pinos Elisabet de See Remarks
Sold at will
$82.27K 16,928 at 4.86
3.6%
Not planned
20 Jan 2026
Leslie Trigg Chair and CEO
Sold at will
$60.39K 11,794 at 5.12
9.9%
Not planned
20 Jan 2026
Chidozie Ugwumba 10% owner · indirect
Sold at will
$59.67K 12,432 at 4.80
1.9%
Not planned
20 Jan 2026
John L. Brottem General Counsel
Sold at will
$47.69K 9,314 at 5.12
20.1%
Not planned
20 Jan 2026
Sold at will
$36.33K 6,522 at 5.57
0.7%
Not planned
20 Jan 2026
Jonathan Harris President and CEO
Sold at will
$30.81K 2,311 at 13.33
0.9%
Not planned
20 Jan 2026
Marc Nash EVP Operations R&D & Service
Sold at will
$27.52K 5,375 at 5.12
11.2%
Not planned
20 Jan 2026
Sold at will
$13.58K 10,000 at 1.36
0.4%
Not planned
20 Jan 2026
Steven P. Coen See remarks
Sold at will
$8.67K 972 at 8.92
10.5%
Not planned
20 Jan 2026
Amy Elazzouzi Senior Vice President, Finance
Sold at will
$7.68K 1,581 at 4.86
1.8%
Not planned
20 Jan 2026
Shane Thomas Gleason Chief Commercial Officer
Sold at will
$4.71K 2,955 at 1.59
0.2%
Not planned
20 Jan 2026
Amanda Crawford Chief Financial Officer
Sold at will
$2.44K 183 at 13.33
0.1%
Not planned
16 Jan 2026
David A Viniar Director
Sold at will 18×
$43.44M 45,000 at 965.33
7.5%
Not planned
16 Jan 2026
Martin Small CFO & Senior Managing Director
Sold at will 4×
$31.68M 27,047 at 1,171.14
71.9%
Sold half or more
16 Jan 2026
David A Viniar Director · indirect
Sold at will 19×
$22.38M 23,186 at 965.27
18.8%
Not planned
16 Jan 2026
Richard Craig Smith Sr. Vice President
Sold at will
$11.17M 3,190 at 3,500.00
54.8%
Sold half or more
16 Jan 2026
Kang Sun Director
Sold at will
$10.52M 950,548 at 11.07
40.4%
Not planned
16 Jan 2026
Wes Cummins CEO; Chairman
Sold at will
$6.01M 165,000 at 36.42
3.8%
Not planned
16 Jan 2026
Mark T Mondello Executive Chairman
Sold at will 2×
$4.30M 17,200 at 250.00
1.5%
Not planned
16 Jan 2026
Sold at will
$4.19M 11,044 at 379.15
18.1%
Not planned
16 Jan 2026
Sold at will
$3.31M 734,747 at 4.50
28.3%
Not planned
16 Jan 2026
Brett P Monia Chief Executive Officer
Sold at will
$3.29M 44,034 at 74.82
16.4%
Not planned
16 Jan 2026
Erik Storey Snell EVP & Chief Cust Exper Officer
Sold at will
$2.80M 39,420 at 71.02
52.5%
Sold half or more
16 Jan 2026
Saba Capital Management, L.P. 10% owner · indirect
Sold at will
$1.20M 75,435 at 15.94
0.3%
Not planned
16 Jan 2026
Sold at will
$1.00M 2,860 at 350.00
16.2%
Not planned
16 Jan 2026
Elizabeth L Hougen EVP, Finance & CFO
Sold at will
$971.99K 12,922 at 75.22
9.3%
Not planned
16 Jan 2026
Bruce R Berkowitz 10% owner
Sold at will
$910.45K 13,900 at 65.50
0.1%
Not planned
16 Jan 2026
Eric Swayze EVP Research
Sold at will
$744.66K 9,884 at 75.34
19.1%
Not planned
16 Jan 2026
Eugene Schneider EVP, Chf Clinical Develop Ofcr
Sold at will
$703.14K 9,302 at 75.59
12.7%
Not planned
16 Jan 2026
Patrick R. O'Neil EVP CLO & General Counsel
Sold at will
$697.05K 9,191 at 75.84
12.2%
Not planned
16 Jan 2026
C Frank Bennett EVP, Chief Scientific Officer
Sold at will
$674.62K 8,977 at 75.15
8.7%
Not planned
16 Jan 2026
Berkshire Hathaway Inc 10% owner · indirect
Sold at will
$643.40K 7,685 at 83.72
0.1%
Not planned
16 Jan 2026
Brian Birchler EVP, Corp and Development Ops
Sold at will
$636.93K 8,480 at 75.11
12.3%
Not planned
16 Jan 2026
Shannon L. Devers EVP, Chief Human Resources Ofc
Sold at will
$634.41K 8,353 at 75.95
24.0%
Not planned
16 Jan 2026
Grant A Brackebusch CFO/Vice President
Sold at will
$633.67K 14,243 at 44.49
10.8%
Not planned
16 Jan 2026
Npeh, LLC 10% owner also filed by 8 Rivers Capital, LLC
Sold at will
$605.48K 230,000 at 2.63
12.9%
Not planned
16 Jan 2026
Joseph Baroldi EVP, Chief Business Officer
Sold at will
$523.21K 6,907 at 75.75
14.6%
Not planned
Showing 18,501–18,550 of 23,037. ← Newer Page 371 of 461 Older →